ANNA ANDERSON: Open Payments
NPI 1881372506 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $148 |
| Abbott Laboratories | 4 | $147 |
| Boston Scientific Corporation | 2 | $133 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $117 |
| Alnylam Pharmaceuticals Inc. | 2 | $54 |
| Amgen Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| HEARTFLOW, INC. | 1 | $14 |
Products named: FABRAZYME, CARDIOMEMS, ACCOLADE SR, LifeVest, AMVUTTRA, REPATHA, WAINUA, VERQUVO.
Industry payments across SD — which companies pay providers there.
